Interleukin-13: central mediator of allergic asthma

The worldwide incidence, morbidity, and mortality of allergic asthma are increasing. The pathophysiological features of allergic asthma are thought to result from the aberrant expansion of CD4(+) T cells producing the type 2 cytokines interleukin-4 (IL-4) and IL-5, although a necessary role for these cytokines in allergic asthma has not been demonstrable. The type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma. IL-13 induces the pathophysiological features of asthma in a manner that is independent of immunoglobulin E and eosinophils. Thus, IL-13 is critical to allergen-induced asthma but operates through mechanisms other than those that are classically implicated in allergic responses.

[1]  W. Leonard,et al.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.

[2]  M. Ebina,et al.  Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. , 1992, Chest.

[3]  D. Marsh,et al.  Relationship among asthma, serum IgE levels and skin test sensitivity to inhaled allergens. , 1993, International archives of allergy and immunology.

[4]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[5]  F. Finkelman,et al.  IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. , 1998, Immunity.

[6]  R. Homer,et al.  Induction of Airway Mucus Production By T Helper 2 (Th2) Cells: A Critical Role For Interleukin 4 In Cell Recruitment But Not Mucus Production , 1997, The Journal of experimental medicine.

[7]  P. Gergen,et al.  Changing patterns of asthma hospitalization among children: 1979 to 1987. , 1990, JAMA.

[8]  A. Buist,et al.  Twenty year trends in hospital discharges for asthma among members of a health maintenance organization. , 1992, Journal of clinical epidemiology.

[9]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Paul,et al.  IL-4 is required to generate and sustain in vivo IgE responses. , 1988, Journal of immunology.

[11]  M. Wills-Karp,et al.  Signal Transducer and Activator of Transcription Factor 6 (Stat6)-deficient Mice Are Protected from Antigen-induced Airway Hyperresponsiveness and Mucus Production , 1998, The Journal of experimental medicine.

[12]  S. Durham,et al.  Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. , 1997, The Journal of allergy and clinical immunology.

[13]  W. Wisden,et al.  Interleukin (IL)-4–independent Induction of Immunoglobulin (Ig)E, and Perturbation of  T Cell Development in Transgenic Mice Expressing IL-13 , 1998, The Journal of experimental medicine.

[14]  J. Stubbe.  One of Nature's Macromolecular Machines Demystified , 1996, Science.

[15]  L. Lichtenstein,et al.  IL-13 expression at the sites of allergen challenge in patients with asthma. , 1995, Journal of immunology.

[16]  F M Chevarley,et al.  National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965-1984. , 1987, Chest.

[17]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[18]  J. Banchereau,et al.  The Primary Binding Subunit of the Human Interleukin-4 Receptor Is Also a Component of the Interleukin-13 Receptor (*) , 1995, The Journal of Biological Chemistry.

[19]  F. Finkelman,et al.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice , 1995, The Journal of experimental medicine.

[20]  M. Schuyler,et al.  Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. , 1991, The American review of respiratory disease.

[21]  G. Zurawski,et al.  Receptor antagonist and selective agonist derivatives of mouse interleukin‐2. , 1992, The EMBO journal.

[22]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[23]  M. Sears,et al.  International trends in asthma mortality: 1970 to 1985. , 1988, Chest.

[24]  E. Bröcker,et al.  Interleukin‐13 selectively induces monocyte chemoattractant protein‐1 synthesis and secretion by human endothelial cells. Involvement of IL‐4Rα and Stat6 phosphorylation , 1997, Immunology.

[25]  J. D. Neely,et al.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. , 1994, Science.

[26]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[27]  G. Gleich.  The eosinophil and bronchial asthma: current understanding. , 1990, The Journal of allergy and clinical immunology.

[28]  R. Pauwels.  The relationship between airway inflammation and bronchial hyperresponsiveness , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[30]  R. Sly.  Increases in deaths from asthma. , 1984, Annals of allergy.

[31]  R. Pauwels,et al.  Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. , 1995, American journal of respiratory cell and molecular biology.

[32]  M. van de Rijn,et al.  Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Rollinson,et al.  Ecology and Genetics of Host-Parasite Interactions , 1986 .

[34]  C. Bertrand,et al.  Interleukin-4 is required for the induction of lung Th2 mucosal immunity. , 1995, American journal of respiratory cell and molecular biology.

[35]  J. Virchow,et al.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.

[36]  P. Newacheck,et al.  Trends in the hospitalization for acute childhood asthma, 1970-84. , 1986, American journal of public health.

[37]  D D Donaldson,et al.  The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. , 1998, Journal of immunology.

[38]  C. Figdor,et al.  Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. , 1993, Research in immunology.

[39]  F. Finkelman,et al.  Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. , 1994, American journal of respiratory cell and molecular biology.

[40]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[41]  R. Strieter,et al.  Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. , 1994, American journal of respiratory cell and molecular biology.

[42]  Ji Ming Wang,et al.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant , 1989, European journal of immunology.

[43]  L. Rosenwasser.  Interleukin-4 and the genetics of atopy. , 1997, The New England journal of medicine.